Worthington Biochemical recently printed a catalog documenting its 2009 to 2010 enzymes, biochemicals and primary cell isolation kits for applications in life science research, diagnostics and biotechnology. According to the company, the catalog is additionally highlighted by:
- The ability to accommodate enzyme requirements from research- to bulk bioprocessing-scale quantities.
- Suitability for primary cell isolation and cell culture, protein research, enzymology and molecular biology applications.
- Both new products, such as the Worthington hepatocyte isolation system, and traditional products.
- Availability of animal origin-free collagenase, DNase, RNase T1 and other enzymes to accommodate the production of regenerative medicine, biopharmaceuticals and vaccines.